Skip to main content
Log in

Variation in KLK genes, prostate-specific antigen and risk of prostate cancer

  • Correspondence
  • Published:

From Nature Genetics

View current issue Submit your manuscript

A Correspondence to this article was published on 01 September 2008

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Associations of tag SNPs in the KLK region with PSA concentrations and prostate cancer risk in the PLCO Trial.

References

  1. Eeles, R.A. et al. Nat. Genet. 40, 316–321 (2008).

    Article  CAS  Google Scholar 

  2. Pal, P. et al. Hum. Genet. 122, 251–259 (2007).

    Article  CAS  PubMed  Google Scholar 

  3. Lai, J. et al. Carcinogenesis 28, 1032–1039 (2007).

    Article  CAS  PubMed  Google Scholar 

  4. Cramer, S.D. et al. J. Natl. Cancer Inst. 95, 1044–1053 (2003).

    Article  CAS  PubMed  Google Scholar 

  5. Prorok, P.C. et al. Control. Clin. Trials 21, 273S–309S (2000).

    Article  CAS  PubMed  Google Scholar 

  6. Thomas, G. et al. Nat. Genet. 40, 310–315 (2008).

    Article  CAS  Google Scholar 

  7. Borgono, C.A. et al. Mol. Cancer Res. 2, 257–280 (2004).

    CAS  PubMed  Google Scholar 

  8. Woolf, S.H. N. Engl. J. Med. 333, 1401–1405 (1995).

    Article  CAS  PubMed  Google Scholar 

  9. de Koning, H.J. et al. Int. J. Cancer 98, 268–273 (2002).

    Article  CAS  PubMed  Google Scholar 

  10. Nam, R.K. et al. J. Clin. Oncol. 21, 2312–2319 (2003).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and by contracts from the Division of Cancer Prevention, National Cancer Institute (NCI), US National Institutes of Health (NIH), Department of Health and Human Services (DHHS). The Health Professionals Follow-up Study (HPFS) study is supported by NIH grants CA55075 and U01CA098233. The American Cancer Society (ACS) study is supported by U01 CA098710. The Alpha Tocopherol Beta-Carotene Cancer Prevention (ATBC) Study is supported by the Intramural Research Program of the National Cancer Institute, NIH, and by US Public Health Service contracts N01-CN-45165, N01-RC-45035 and N01-RC-37004 from the National Cancer Institute, NIH, DHHS. A.S.K is supported by RO1CA112028. The genome-wide scans have been supported by the NCI, NIH, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the DHHS, nor does mention of trade names, commercial products or organizations imply endorsement by the US government.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard B Hayes.

Supplementary information

Supplementary Text and Figures

Supplementary Figure 1, Supplementary Tables 1–6, Supplementary Methods (PDF 418 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahn, J., Berndt, S., Wacholder, S. et al. Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet 40, 1032–1034 (2008). https://doi.org/10.1038/ng0908-1032

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng0908-1032

  • Springer Nature America, Inc.

This article is cited by

Navigation